AIP and metabolic disease: Specifically, CHARLS’repeated AIP measurements allow us to calculate CumAIP (time-weighted cumulative AIP exposure), while its detailed demographic and clinical data enable rigorous adjustment for confounders (e.g., metabolic disorders, vascular pathologies) that could obscure the CumAIP–dementia association.